AMARIN CORP PLC\UK Amortization of Debt Issuance Costs and Discounts
AMARIN CORP PLC\UK (AMRN) reported Amortization of Debt Issuance Costs and Discounts of $635.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2023-03-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2023-03-01
- AMARIN CORP PLC\UK amortization of debt issuance costs and discounts for the quarter ending 2020-12-31 was $34.00K, a 90.61% decline year-over-year.
- AMARIN CORP PLC\UK amortization of debt issuance costs and discounts for the quarter ending 2020-09-30 was $111.00K, a 72.52% decline year-over-year.
- AMARIN CORP PLC\UK amortization of debt issuance costs and discounts for the quarter ending 2020-06-30 was $201.00K, a 53.47% decline year-over-year.
- AMARIN CORP PLC\UK amortization of debt issuance costs and discounts for the quarter ending 2020-03-31 was $289.00K, a 35.20% decline year-over-year.
- AMARIN CORP PLC\UK amortization of debt issuance costs and discounts for fiscal 2020 was $635.00K, a 61.37% decline from fiscal 2019.
- AMARIN CORP PLC\UK amortization of debt issuance costs and discounts for fiscal 2019 was $1.64M, a 24.69% decline from fiscal 2018.
- AMARIN CORP PLC\UK amortization of debt issuance costs and discounts for fiscal 2018 was $2.18M, a 6.39% decline from fiscal 2017.
- AMARIN CORP PLC\UK amortization of debt issuance costs and discounts for fiscal 2017 was $2.33M, a 70.04% decline from fiscal 2016.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2020-12-31 | $34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $145.00K derived: sum of 2 quarters · filed 2023-03-01 | $346.00K derived: sum of 3 quarters · filed 2023-03-01 | $635.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | $111.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $312.00K derived: sum of 2 quarters · filed 2021-11-03 | $601.00K 10-Q · filed 2021-11-03 | $963.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $201.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $490.00K 10-Q · filed 2021-08-05 | $852.00K derived: sum of 3 quarters · filed 2022-03-01 | $1.26M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $289.00K 10-Q · filed 2021-04-29 | $651.00K derived: sum of 2 quarters · filed 2022-03-01 | $1.05M derived: sum of 3 quarters · filed 2022-03-01 | $1.49M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $362.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $766.00K derived: sum of 2 quarters · filed 2022-03-01 | $1.20M derived: sum of 3 quarters · filed 2022-03-01 | $1.64M 10-K · filed 2022-03-01 |
| 2019-09-30 | $404.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $836.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.28M 10-Q · filed 2020-11-05 | $1.78M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $432.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $878.00K 10-Q · filed 2020-08-04 | $1.37M derived: sum of 3 quarters · filed 2021-02-25 | $1.92M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $446.00K 10-Q · filed 2020-04-30 | $942.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.49M derived: sum of 3 quarters · filed 2021-02-25 | $2.06M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $496.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.04M derived: sum of 2 quarters · filed 2021-02-25 | $1.61M derived: sum of 3 quarters · filed 2021-02-25 | $2.18M 10-K · filed 2021-02-25 |
| 2018-09-30 | $547.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $1.11M derived: sum of 2 quarters · filed 2019-11-05 | $1.69M 10-Q · filed 2019-11-05 | $2.28M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $567.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $1.14M 10-Q · filed 2019-07-31 | $1.74M derived: sum of 3 quarters · filed 2020-02-25 | $2.33M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $573.00K 10-Q · filed 2019-05-01 | $1.17M derived: sum of 2 quarters · filed 2020-02-25 | $1.76M derived: sum of 3 quarters · filed 2020-02-25 | $2.34M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $596.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $1.19M derived: sum of 2 quarters · filed 2020-02-25 | $1.77M derived: sum of 3 quarters · filed 2020-02-25 | $2.33M 10-K · filed 2020-02-25 |
| 2017-09-30 | $589.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $1.17M derived: sum of 2 quarters · filed 2018-11-01 | $1.74M 10-Q · filed 2018-11-01 | $2.27M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $584.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $1.15M 10-Q · filed 2018-08-01 | $1.68M derived: sum of 3 quarters · filed 2019-02-27 | $3.89M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $563.00K 10-Q · filed 2018-05-02 | $1.10M derived: sum of 2 quarters · filed 2019-02-27 | $3.31M derived: sum of 3 quarters · filed 2019-02-27 | $5.87M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $537.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $2.75M derived: sum of 2 quarters · filed 2019-02-27 | $5.31M derived: sum of 3 quarters · filed 2019-02-27 | $7.78M 10-K · filed 2019-02-27 |
| 2016-09-30 | $2.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $4.77M derived: sum of 2 quarters · filed 2017-11-01 | $7.25M 10-Q · filed 2017-11-01 | $9.85M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $2.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $5.04M 10-Q · filed 2017-08-02 | $7.64M derived: sum of 3 quarters · filed 2018-02-27 | $9.61M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $2.47M 10-Q · filed 2017-05-03 | $5.08M derived: sum of 2 quarters · filed 2018-02-27 | $7.04M derived: sum of 3 quarters · filed 2018-02-27 | $8.92M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $4.57M derived: sum of 2 quarters · filed 2018-02-27 | $6.45M derived: sum of 3 quarters · filed 2018-02-27 | $8.26M 10-K · filed 2018-02-27 |
| 2015-09-30 | $1.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $3.84M derived: sum of 2 quarters · filed 2016-11-03 | $5.65M 10-Q · filed 2016-11-03 | $7.48M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $3.69M 10-Q · filed 2016-08-04 | $5.51M derived: sum of 3 quarters · filed 2017-03-01 | $7.28M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $1.81M 10-Q · filed 2016-05-05 | $3.63M derived: sum of 2 quarters · filed 2017-03-01 | $5.41M derived: sum of 3 quarters · filed 2017-03-01 | $6.50M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $3.60M derived: sum of 2 quarters · filed 2017-03-01 | $4.69M derived: sum of 3 quarters · filed 2017-03-01 | $5.86M 10-K · filed 2017-03-01 |
| 2014-09-30 | $1.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $2.87M derived: sum of 2 quarters · filed 2015-11-04 | $4.04M 10-Q · filed 2015-11-04 | $8.44M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $2.27M 10-Q · filed 2015-08-06 | $6.67M derived: sum of 3 quarters · filed 2016-02-25 | $11.16M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $1.17M 10-Q · filed 2015-05-08 | $5.57M derived: sum of 2 quarters · filed 2016-02-25 | $10.06M derived: sum of 3 quarters · filed 2016-02-25 | $14.60M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $8.89M derived: sum of 2 quarters · filed 2016-02-25 | $13.43M derived: sum of 3 quarters · filed 2016-02-25 | $17.63M 10-K · filed 2016-02-25 |
| 2013-09-30 | $4.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $9.03M derived: sum of 2 quarters · filed 2014-11-06 | $13.23M 10-Q · filed 2014-11-06 | $16.72M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-06-30 | $4.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $8.74M 10-Q · filed 2014-08-07 | $12.23M derived: sum of 3 quarters · filed 2015-03-03 | $15.58M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-03-31 | $4.20M 10-Q · filed 2014-05-09 | $7.70M derived: sum of 2 quarters · filed 2015-03-03 | $11.04M derived: sum of 3 quarters · filed 2015-03-03 | |
| 2012-12-31 | $3.49M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $6.84M derived: sum of 2 quarters · filed 2015-03-03 | $12.86M 10-K · filed 2015-03-03 | |
| 2012-09-30 | $3.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $9.37M 10-Q · filed 2013-11-07 | ||
| 2012-06-30 | $6.02M 10-Q · filed 2013-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |